US-Based RICOVR Healthcare and IIT Madras Receive ‘Ignition Grants’ Award for COVID-19 Diagnostic Device

US-Based RICOVR Healthcare and IIT Madras Receive ‘Ignition Grants’ Award for COVID-19 Diagnostic Device

RICOVR Healthcare and IIT Madras

RICOVR Healthcare and IIT Madras

RICOVR Healthcare and IIT Madras

Princeton, USA, Sept. 15, 2020 (GLOBE NEWSWIRE) — The Biosensor Platform uses a small drop of saliva to provide high quality, cost-effective results in 5 minutes & detect active viral particles on the spot without needing a specialized apparatus

RICOVR Healthcare Inc., an US-based rapid diagnostics platform company and IIT Madras have developed a revolutionary point-of-care COVID-19 antigen test that can provide results in five minutes using saliva. This project won the prestigious ‘Ignition Grants’ Award from the U.S. India Science and Technology Endowment Fund (USISTEF).” data-reactid=”31″>RICOVR Healthcare Inc., an US-based rapid diagnostics platform company and IIT Madras have developed a revolutionary point-of-care COVID-19 antigen test that can provide results in five minutes using saliva. This project won the prestigious ‘Ignition Grants’ Award from the U.S. India Science and Technology Endowment Fund (USISTEF).

USISTEF, a joint fund established by the U.S. and India to promote innovation through science and technology, announced the results recently after a rigorous binational review process of over 400 proposals, The Ricovr-IIT Madras team was selected for its out-of-the-box, innovative idea to address the COVID-19 challenge.

RICOVR Healthcare’s patented biosensor platform uses a small drop of saliva to provide high-quality, cost-effective results in approximately five minutes. IIT Madras is collaborating with RICOVR to bring this novel COVID-19 antigen test to the market. The innovative approach of detection and simple use of saliva will help bring a cost-effective, accurate, and user-friendly device to global markets in need of more immediate diagnostic tools.

The RICOVR and IIT Madras collaboration is intended to support a successful joint U.S.-India entrepreneurial initiative devoted to battle COVID-19. It focuses on developing and implementing new technologies and systems to satisfy unmet rapid and reliable testing needs. RICOVR Healthcare is one step closer to bringing the Point-of-care Fiber-optic Biosensor (P-FAB) Device from the lab to the market. 

COVID-19 Ignition Grants’ in April 2020. The intent was to support promising joint U.S.-India entrepreneurial initiatives that address the development and implementation of new technologies, tools, and systems to address COVID-19 related challenges, including monitoring, diagnosis, health and safety, public outreach, information, and communications. ” data-reactid=”37″>The USISTEF had called for proposals under the category of ‘COVID-19 Ignition Grants’ in April 2020. The intent was to support promising joint U.S.-India entrepreneurial initiatives that address the development and implementation of new technologies, tools, and systems to address COVID-19 related challenges, including monitoring, diagnosis, health and safety, public outreach, information, and communications. 

RICOVR” data-reactid=”44″>About RICOVR

https://www.ricovr.com/.
” data-reactid=”45″>RICOVR, a leader in the oral diagnostics and testing market, was founded by Dr. Himanshu Bhatia, a physician executive with a deep background in medical devices and biotechnology. Along with Piyush Sadana, co-founder and seasoned entrepreneur with an investment banking and deep tech background, the firm boasts a distinguished advisory board and management team of scientists and engineers committed to making a positive impact on society. The company has strong partnerships with leading research and development institutions around the globe. To learn more about Ricovr, visit https://www.ricovr.com/.

RicovrHealth” data-reactid=”46″>Follow RICOVR on Facebook: RicovrHealth

@ricovr_health ” data-reactid=”47″>Follow RICOVR on Twitter: @ricovr_health 

info@ricovr.com” data-reactid=”49″>Kyle Muse – info@ricovr.com

IIT MADRAS” data-reactid=”50″>ABOUT IIT MADRAS

IITM Incubation Cell.” data-reactid=”51″>Indian Institute of Technology Madras (IITM) was established in 1959 by the Government of India as an ‘Institute of National Importance.’ The activities of the Institute in various fields of Science and Technology are carried out in 16 academic departments and several advanced interdisciplinary research academic centres. The Institute offers undergraduate and postgraduate programmes leading to B.Tech., M.Sc., M.B.A., M.Tech., M.S., and Ph.D., degrees in a variety of specialisations. IITM is a residential institute with more than 580 faculty and 9,500 students. Students from 18 countries are enrolled here. IITM fosters an active entrepreneurial culture with strong curricular support and through the IITM Incubation Cell.

Overall’ Category for the second consecutive year in India Ranking 2020 released by National Institutional Ranking Framework, Ministry of Education, Govt. of India. The Institute has also been ranked No.1 in the ‘Engineering Institutions’ category in the same Rankings for five consecutive years – 2016, 2017, 2018, 2019 and 2020. It was also adjudged as the ‘Top innovative Institution’ in the country in Atal Ranking of Institutions on Innovation Achievements (ARIIA) in 2019 and 2020. ARIIA Ranking was launched by the Innovation Cell of Ministry of Education.” data-reactid=”52″>IITM has been ranked No.1 in the ‘Overall’ Category for the second consecutive year in India Ranking 2020 released by National Institutional Ranking Framework, Ministry of Education, Govt. of India. The Institute has also been ranked No.1 in the ‘Engineering Institutions’ category in the same Rankings for five consecutive years – 2016, 2017, 2018, 2019 and 2020. It was also adjudged as the ‘Top innovative Institution’ in the country in Atal Ranking of Institutions on Innovation Achievements (ARIIA) in 2019 and 2020. ARIIA Ranking was launched by the Innovation Cell of Ministry of Education.

ReachIITM
Follow IIT Madras on Twitter: @iitmadras” data-reactid=”53″>Follow IIT Madras on Facebook: ReachIITM
Follow IIT Madras on Twitter: @iitmadras

Footprint Global Communications
Cell: 9999500262 / Email: bhavani.giddu@footprintglobal.com
Sairam Radhakrishnan- IIT Madras Media Cell, Chennai 
Cell: 9840108083/ Email: sairam.radhakrishnan@footprintglobal.com
Manmohan Negi – Footprint Global Communications
Cell: 96541 15779/ Email: manmohan.negi@footprintglobal.com

Media Details:
Company Name – RICOVR Healthcare Inc.
Company E-mail – info@ricovr.com
Company website – www.ricovr.com ” data-reactid=”55″>Bhavani Giddu – Footprint Global Communications
Cell: 9999500262 / Email: bhavani.giddu@footprintglobal.com
Sairam Radhakrishnan- IIT Madras Media Cell, Chennai 
Cell: 9840108083/ Email: sairam.radhakrishnan@footprintglobal.com
Manmohan Negi – Footprint Global Communications
Cell: 96541 15779/ Email: manmohan.negi@footprintglobal.com

Media Details:
Company Name – RICOVR Healthcare Inc.
Company E-mail – info@ricovr.com
Company website – www.ricovr.com 

Source Article